The results achieved by the Oslo Innovation Centre are impressive as it pursues its mission to identify and help transform companies showing commercially promising research results and project ideas. The goal is development into profitable enterprises, facilitated by a focus on sound commercial fundamentals. An active business development partner, the Centre also provides professional facilities conducive to creativity and growth.
From a bird’s-eye perspective, working with many diverse companies in various stages of development enables the Centre’s leadership to identify synergies and cooperative possibilities that might have otherwise gone unnoticed. This is all done in dynamic international surroundings where it is natural to keep a “finger on the pulse” on the wide and diverse range of research activities.
A recent survey shows many employees working with companies at the Centre are from outside of Norway, creating an environment truly mirroring sectors of the international research world. In fact, foreign companies frequently approach the Centre to gain a better understanding of developments, and often lease office space to work more closely with the innovative activities here.
From Start to Success
The process begins when companies approach – or are approached by –
the Oslo Innovation Centre, and are identified as having potential for success. Companies then work together with the Centre, from start-up through to final development, marketing and commercial success. Support may take the form of assistance to finalize a business plan, seek funding, pinpoint target markets, develop marketing programs – in other words – the Centre provides sound guidance through all phases.
There are a number of excellent examples of companies on the road to success, including Lauras, with research centring on development of immunostimulatory drugs that stimulate and improve the function of the immune system. Lauras’ research is especially focused on HIV infection, common variable immunodeficiency as well as certain types of cancer, all based on new knowledge showing that activation of a signal pathway inside the immune cells inhibits the function of the immune system.
Also working to improve life quality is OstomyCure, developer of the first-ever implantable device compatible with living soft tissue. The next major milestone will be testing in humans, beginning during 2008. According to Christer Jacobsson, OstomyCure CEO; “The fact that tests show our implantable device is accepted by soft tissue represents a potential major breakthrough with possible uses in many other applications. We look forward to presenting our findings to the 8th World Biomaterials Congress in Amsterdam.”
The Oslo Innovation Centre aims to be a European leader for innovation and business development – with many companies on the road to success. When in Norway, come to the centre for innovation, the Oslo Innovation Centre.